{"result": "(\"entity\"<|>NUTRICIÓN<|>EVENT<|>Nutritional assessment and intervention are critical for patients with head and neck neoplasms to prevent worsening of their condition and improve survival rates.)\n##\n(\"entity\"<|>DESNUTRICIÓN<|>EVENT<|>Desnutrición is a condition that can arise in patients with head and neck cancers due to the impact of the tumor and its treatment on nutritional intake.)\n##\n(\"entity\"<|>RIESGO NUTRICIONAL<|>EVENT<|>Riesgo nutricional refers to the potential for patients with head and neck neoplasms to experience nutritional deficiencies, which can affect their treatment outcomes.)\n##\n(\"entity\"<|>TRATAMIENTO QUIRÚRGICO<|>EVENT<|>Tratamiento quirúrgico is a medical intervention that may be necessary for patients with carcinoma epidermoide de laringe, impacting their nutritional status.)\n##\n(\"entity\"<|>QUIMIOTERAPIA<|>EVENT<|>Quimioterapia is a treatment option for cancer patients that can lead to side effects affecting nutrition, such as nausea and loss of appetite.)\n##\n(\"entity\"<|>RADIOTERAPIA<|>EVENT<|>Radioterapia is a common treatment for head and neck cancers that can cause complications impacting a patient's nutritional intake.)\n##\n(\"entity\"<|>AFAGIA<|>EVENT<|>Afagia is a condition characterized by the inability to swallow, often associated with head and neck cancers, leading to significant nutritional challenges.)\n##\n(\"entity\"<|>DISFAGIA<|>EVENT<|>Disfagia is a swallowing disorder that can occur in patients with head and neck neoplasms, contributing to nutritional risks.)\n##\n(\"entity\"<|>HIPOGLUCEMIA<|>EVENT<|>Hipoglucemia refers to low blood sugar levels, which can be a concern for patients with diabetes mellitus tipo 2, especially those undergoing treatment.)\n##\n(\"entity\"<|>INSULINA<|>EVENT<|>Insulina is a hormone used in the management of diabetes mellitus tipo 2, crucial for maintaining blood sugar levels in the patient.)\n##\n(\"entity\"<|>METFORMINA<|>EVENT<|>Metformina is a medication used to treat type 2 diabetes, helping to control blood sugar levels in the patient.)\n##\n(\"entity\"<|>PIOGLITAZONA<|>EVENT<|>Pioglitazona is a medication that may be used in conjunction with metformin for managing diabetes mellitus tipo 2.)\n##\n(\"entity\"<|>AAS<|>EVENT<|>AAS (Acetylsalicylic Acid) is a medication that may be prescribed for cardiovascular protection in patients with diabetes.)\n##\n(\"entity\"<|>EZETIMIBE<|>EVENT<|>Ezetimibe is a medication used to lower cholesterol levels, which may be relevant for the patient's overall health management.)\n##\n(\"entity\"<|>ATORVASTATINA<|>EVENT<|>Atorvastatina is a statin medication used to manage cholesterol levels, important for patients with diabetes and cardiovascular risks.)\n##\n(\"entity\"<|>IRBESARTAN<|>EVENT<|>Irbesartán is an antihypertensive medication that may be prescribed to manage blood pressure in patients with diabetes.)\n##\n(\"entity\"<|>HIDROCLOROTIAZIDA<|>EVENT<|>Hidroclorotiazida is a diuretic used to treat high blood pressure, which may be relevant for the patient's overall health management.)\n##\n(\"relationship\"<|>PACIENTE<|>NUTRICIÓN<|>The patient requires nutritional assessment and intervention due to the impact of his cancer and treatments on his nutritional status.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>DESNUTRICIÓN<|>The patient is at risk of desnutrición due to his head and neck cancer and associated treatments, necessitating close monitoring.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>RIESGO NUTRICIONAL<|>The patient has a high riesgo nutricional due to his medical conditions, which complicates his treatment and recovery.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>TRATAMIENTO QUIRÚRGICO<|>The patient underwent tratamiento quirúrgico for carcinoma epidermoide de laringe, impacting his nutritional needs.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>QUIMIOTERAPIA<|>The patient may receive quimioterapia as part of his cancer treatment, which can affect his nutritional intake.<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>RADIOTERAPIA<|>The patient may undergo radioterapia, which can lead to side effects that impact his ability to eat and maintain nutrition.<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>AFAGIA<|>The patient experiences afagia as a result of his cancer, significantly affecting his nutritional status.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>DISFAGIA<|>The patient suffers from disfagia, which complicates his ability to consume adequate nutrition.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>HIPOGLUCEMIA<|>The patient is at risk of hipoglucemia due to his diabetes management, which must be carefully monitored.<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>INSULINA<|>The patient is treated with insulina to manage his diabetes, which is crucial for his overall health.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>METFORMINA<|>The patient is prescribed metformina as part of his diabetes management regimen.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>PIOGLITAZONA<|>The patient is also taking pioglitazona to help control his blood sugar levels.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>AAS<|>The patient is prescribed AAS for cardiovascular protection, which is important given his diabetes.<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>EZETIMIBE<|>The patient is on ezetimibe to manage cholesterol levels, which is relevant for his overall health.<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>ATORVASTATINA<|>The patient is taking atorvastatina to help control his cholesterol levels, which is important for his health management.<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>IRBESARTAN<|>The patient is prescribed irbesartán to manage his blood pressure, which is crucial for his overall health.<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>HIDROCLOROTIAZIDA<|>The patient is also taking hidroclorotiazida as part of his treatment for hypertension.<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: hay recidiva de la neopla-\nsia, por lo que se ha retirado la GRP y sigue controles en CCEE.\n\n\n\nPalabras clave\n         Carcinoma epidermoide de laringe, diabetesmellitus tipo 2, gastrostomía radio-\nlógica percutánea, radioterapia, laringuectomía total, desnutrición, riesgo nutricional,\ninmunonutrición, disfagia, suplementos nutricionales orales.\n\n\n\n                                                                                                          137\n---\n     Introducción\n              Las neoplasias de cabeza y cuello son la séptima patología oncológica más\n     frecuente, presentándose en la mayoría de los pacientes como una neoplasia localmen-\n     te avanzada al diagnóstico. Requieren de un manejo multidisciplinar1 .\n              Estas neoplasias están estrechamente relacionadas con la desnutrición. Ya de\n     por sí, su presencia, es un riesgo nutricional para el paciente independientemente de\n     su estado nutricional previo1,2 .\n              El riesgo de desnutrición o su presencia ya establecida puede ser consecuencia,\n     por un lado, del propio tumor y su tamaño, a través de la disfagia y/o afagia que asocia.\n     Y por otro lado, de los tratamientos posteriores que va a recibir el paciente, que son\n     un importante factor que va a contribuir a ello, a través del tratamiento quirúrgico, y\n     también secundario al tratamiento con quimioterapia (QT) o RT, que pueden causar:\n     alteraciones del gusto, mucositis, xerostomía, fatiga, disfagia, náuseas y vómitos1 .\n              Se acepta incluso y así está presente en numerosos estudios, que hay una pér-\n     dida de peso incondicional de entre un 8-10% en estos pacientes asociada a los trata-\n     mientos recibidos, a pesar de que la intervención nutricional sea precoz1,3 .\n              Por tanto, dado este contexto, se recomienda que se haga un cribado nutricional\n     al diagnóstico a todos aquellos pacientes con patología oncológica de cabeza y cuello,\n     siendo derivados a un especialista en caso de que presente un riesgo alto nutricional2 .\n     De ahí la importancia que tiene la valoración y la intervención nutricional precoz en\n     estos pacientes, para no empeorar el pronóstico y la supervivencia, así como un segui-\n     miento nutricional a lo largo de la evolución de la patología oncológica1,4 .\n              Por otro lado, la DM es una patología también prevalente y cada vez más pre-\n     sente. Las últimas cifras hablan de una prevalencia en España, ya sea diagnosticada\n     o por diagnosticar cercana al 12% del total de la población5 . Con todo esto, puede ser\n     habitual en la práctica clínica diaria encontrar a pacientes con una neoplasia de cabeza\n     y cuello y con DM concomitante asociada, como el correspondiente al de nuestro caso\n     clínico. Dicha situación es importante tenerla en cuenta a la hora de planificar cual va\n     a ser la mejor fórmula de NE y ajustar estrechamente el tratamiento para la DM, espe-\n     cialmente en aquellos que estén en tratamiento con insulina.\n\n\n\n     Caso clínico\n              Motivo de interconsulta a la UN:\n              “Paciente intervenido de LT y portador de GRP, solicitamos valoración para\n     instaurar nutrición.”\n\n\n\n138\n---\n         Antecedentes:\n         No RAM.\n         Ex-fumador de 40 cigarrillos al día desde hace 2 años. Ex-alcoholismo desde hace\n         10 años.\n         Carcinoma epidermoide de laringe. Diabetes Mellitus tipo 2 de 15 años de evolu-\n         ción en tratamiento con insulina desde hace 5 años. Última HbA1c de 7.1%, segui-\n         miento en Centro de especialidades.               Hipertensión arterial. Dislipemia. Parálisis\n         facial periférica.\n         Intervenciones quirúrgicas: apendicectomía.\n         Tratamiento habitual: Insulina Glargina 300 UI/mL 38 UI cada 24 horas,                         Metfor-\n         mina/Pioglitazona 850/15 mg 1 cada 12 horas, AAS 100 mg, Ezetimibe/Atorvasta-\n         tina 10/40 mg 1 cada 24 horas, Irbesartan/Hidroclorotiazida 300/25 mg 1 cada 24\n         horas.\n         Situación basal: independencia para las actividades básicas de la vida diaria.\n         No deterioro cognitivo.\n\n\n\n         Enfermedad/historia actual:\n         Varón de 66 años ingresado en ORL para LT y vaciamiento funcional derecho en\ncontexto de carcinoma epidermoide de laringe.\n\n\n\n         El paciente inicialmente se remitió a CCEE de Otorrinolaringología (\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>CARCINOMA EPIDERMOIDE DE LARINGE<|>EVENT<|>Carcinoma epidermoide de laringe is a type of cancer affecting the larynx, often requiring surgical intervention and associated with nutritional risks due to swallowing difficulties.)\n##\n(\"entity\"<|>DIABETES MELLITUS TIPO 2<|>EVENT<|>Diabetes Mellitus tipo 2 is a chronic condition that affects the way the body processes blood sugar (glucose), requiring management through medication and lifestyle changes.)\n##\n(\"entity\"<|>GRP<|>ORGANIZATION<|>GRP refers to a medical device or procedure used in the management of patients with certain conditions, including those requiring nutritional support.)\n##\n(\"entity\"<|>UN<|>ORGANIZATION<|>UN refers to a unit or department within a healthcare facility that specializes in nutritional assessment and intervention.)\n##\n(\"entity\"<|>ORL<|>ORGANIZATION<|>ORL refers to the department of Otorrinolaringología, which specializes in ear, nose, and throat conditions, including surgeries related to laryngeal cancer.)\n##\n(\"entity\"<|>PACIENTE<|>PERSON<|>The patient is a 66-year-old male who has undergone surgery for laryngeal cancer and is being evaluated for nutritional support due to his medical conditions.)\n##\n(\"entity\"<|>CCEE<|>ORGANIZATION<|>CCEE refers to the Centro de Especialidades, a specialized healthcare center for managing complex medical cases.)\n##\n(\"relationship\"<|>PACIENTE<|>CARCINOMA EPIDERMOIDE DE LARINGE<|>The patient has been diagnosed with carcinoma epidermoide de laringe, which is the reason for his surgical intervention and nutritional assessment.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>DIABETES MELLITUS TIPO 2<|>The patient has a history of diabetes mellitus tipo 2, which complicates his overall health management and nutritional needs.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>GRP<|>The patient is a portador de GRP, indicating the use of this medical device for nutritional support following his surgery.<|>6)\n##\n(\"relationship\"<|>PACIENTE<|>UN<|>The patient is being referred to the UN for nutritional evaluation and support due to his medical conditions.<|>7)\n##\n(\"relationship\"<|>PACIENTE<|>ORL<|>The patient is admitted to the ORL department for laryngeal surgery related to his cancer diagnosis.<|>8)\n##\n(\"relationship\"<|>PACIENTE<|>CCEE<|>The patient was initially referred to CCEE for specialized care in managing his nutritional needs post-surgery.<|>7)\n<|COMPLETE|>"}]}